GSTM1 and prostate cancer: To evaluate the potential cumulative effect of these GST polymorphisms on susceptibility to prostate cancer development, a regression analysis was performed based on the number of risk-associated alleles per individual (GSTM1*active, GSTT1*null, GSTP1*Val rs1695 and GSTP1*Val rs1138272).